Even as it’s become clear that an inherited susceptibility to some cancers is more common than once thought, genetic testing of family members of cancer patients hasn’t increased as much as experts had hoped.
Feasibility Study with Evonik Confirms LEON’s FR-JET Technology’s Performance in Advanced Nanoparticle Manufacturing for Drug Delivery – Biotech Investments
EQS-News: leon-nanodrugs GmbH / Key word(s): Study results Feasibility Study with Evonik Confirms LEON’s FR-JET Technology’s Performance in Advanced Nanoparticle Manufacturing for Drug Delivery 05.12.2024